10/2025 EUnetCCC | Study Visit and Opening Workshop – Ukraine National Cancer Institute
The week from October 27 to 31, 2025 marked an important milestone in the collaboration between the Joint Action EUnetCCC and the National Cancer Institute (NCI) of Ukraine.
Despite the ongoing challenges in their home country, three colleagues from the NCI, Dr. Yurii Kondratskyi, Mykyta Pepenin and Oleksii Dobrzhanskyi, joined us to exchange experiences, learn from certified cancer centres in Germany, and discuss the first steps towards setting up a Comprehensive Cancer Care Network (CCCN) in Kyiv.
The visit began at the University Hospital Chemnitz, Clinic for Thoracic, Angio- and Endovascular Surgery, a longstanding DKG-certified Lung Cancer Center. Dr. Sven Seifert and his team warmly welcomed the delegation and shared insights into their work. Over two intensive days, the group explored the structure and workflow of multidisciplinary teams, observed procedures in minimally invasive and robotic surgery, and attended tumor boards in thoracic and visceral oncology.
Dr. Seifert and his colleagues shared their remarkable experience in developing high-quality, patient-centred care, demonstrating how coordinated multidisciplinary collaboration can make a measurable difference for patients.
On October 31, the group met in Berlin for the Opening Workshop, hosted by the German Cancer Society (DKG). The meeting focused on practical aspects of implementing a CCCN, reviewing the Set of Standards, the CCCN Partner Matrix, and approaches to Data Management, Quality Indicators, and Patient Pathways.
Special thanks to our partners Dr. Nikolai Goncharenko (Luxembourg Institut National du Cancer (INC)), and Dr. Sergej Popovich (MammoLOAD), who kindly joined the meeting and shared their extensive experience with certification processes.
This week laid the foundation for further collaboration between Ukraine NCI and EUnetCCC WP9 to establish a sustainable and high-quality pilot CCCN in Ukraine.
Together, we take another step toward improving access to comprehensive, high-quality cancer care for all patients in Europe.









